Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Neurol ; 16: 170, 2016 Sep 13.
Article in English | MEDLINE | ID: mdl-27618987

ABSTRACT

BACKGROUND: Natural killer (NK) cells comprise the main components of lymphocyte-mediated nonspecific immunity. Through their effector function they play a crucial role combating bacterial and viral challenges. They are also thought to be key contributors to the systemic spinal cord injury-induced immune-deficiency syndrome (SCI-IDS). SCI-IDS increases susceptibility to infection and extends to the post-acute and chronic phases after SCI. METHODS AND DESIGN: The prospective study of NK cell function after traumatic SCI was carried out in two centers in Berlin, Germany. SCI patients and control patients with neurologically silent vertebral fracture also undergoing surgical stabilization were enrolled. Furthermore healthy controls were included to provide reference data. The NK cell function was assessed at 7 (5-9) days, 14 days (11-28) days, and 10 (8-12) weeks post-trauma. Clinical documentation included the American Spinal Injury Association (ASIA) impairment scale (AIS), neurological level of injury, infection status, concomitant injury, and medications. The primary endpoint of the study is CD107a expression by NK cells (cytotoxicity marker) 8-12 weeks following SCI. Secondary endpoints are the NK cell's TNF-α and IFN-γ production by the NK cells 8-12 weeks following SCI. DISCUSSION: The protocol of this study was developed to investigate the hypotheses whether i) SCI impairs NK cell function throughout the post-acute and sub-acute phases after SCI and ii) the degree of impairment relates to lesion height and severity. A deeper understanding of the SCI-IDS is crucial to enable strategies for prevention of infections, which are associated with poor neurological outcome and elevated mortality. TRIAL REGISTRATION: DRKS00009855 .


Subject(s)
Killer Cells, Natural/immunology , Spinal Cord Injuries/immunology , Adult , Biomarkers , Case-Control Studies , Cells, Cultured , Clinical Protocols , Humans , Interferon-gamma/biosynthesis , Killer Cells, Natural/metabolism , Longitudinal Studies , Lysosomal-Associated Membrane Protein 1/biosynthesis , Male , Prospective Studies , Spinal Cord Injuries/complications , Time Factors , Tumor Necrosis Factor-alpha/biosynthesis , Young Adult
2.
Eur J Immunol ; 44(9): 2822-34, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24895051

ABSTRACT

Haploidentical stem cell transplantation (haploSCT) offers an alternative treatment option for advanced leukemia patients lacking a HLA-compatible donor. Transfer of NK cells represents a promising therapeutic option in combination with SCT, as NK cells can promote graft versus leukemia with low risk of GVH disease. In this study, we show results from a phase I/II trial in which 24 acute myeloid leukemia patients underwent haploSCT in combination with early transfer of unmodified NK cells and observed a promising 2-year overall survival rate of 37%. By performing immunomonitoring and subsequent principal component analysis, we tracked donor NK-cell dynamics in the patients and distinguished between NK cells reconstituting from CD34(+) precursors, giving rise over time to a continuum of multiple differentiation stages, and adoptively transferred NK cells. Transferred NK cells displayed a mature phenotype and proliferated in vivo during the early days after haploSCT even in the absence of exogenous IL-2 administration. Moreover, we identified the NK-cell phenotype associated with in vivo expansion. Thus, our study indicates a promising path for adoptive transfer of unmodified NK cells in the treatment of high-risk acute myeloid leukemia.


Subject(s)
Killer Cells, Natural/immunology , Leukemia, Myeloid, Acute , Stem Cell Transplantation , Unrelated Donors , Adult , Antineoplastic Agents/pharmacology , Cell Proliferation/drug effects , Disease-Free Survival , Female , Follow-Up Studies , Humans , Interleukin-2/pharmacology , Killer Cells, Natural/pathology , Leukemia, Myeloid, Acute/immunology , Leukemia, Myeloid, Acute/mortality , Leukemia, Myeloid, Acute/therapy , Male , Middle Aged , Phenotype , Risk Factors , Survival Rate
3.
Front Immunol ; 5: 142, 2014.
Article in English | MEDLINE | ID: mdl-24744763

ABSTRACT

During the early phase of an inflammatory response, innate cells can use different strategies to sense environmental danger. These include the direct interaction of specific activating receptors with pathogen-encoded/danger molecules or the engagement of cytokine receptors by pro-inflammatory mediators produced by antigen presenting cells in the course of the infection. These general recognition strategies, which have been extensively described for innate myeloid cells, are shared by innate lymphoid cells (ILC), such as Natural Killer (NK) cells. The family of ILC has recently expanded with the discovery of group 2 (ILC2) and group 3 ILC (ILC3), which play an important role in the defense against extracellular pathogens. Although ILC3 and NK cells share some phenotypic characteristics, the recognition strategies employed by the various ILC3 subsets have been only partially characterized. In this review, we will describe and comparatively discuss how ILC3 sense environmental cues and how the triggering of different receptors may regulate their functional behavior during an immune response.

4.
J Immunol ; 192(7): 3091-100, 2014 Apr 01.
Article in English | MEDLINE | ID: mdl-24567530

ABSTRACT

Memory B cells (mBCs) are a key to immunologic memory, yet their distribution within lymphoid organs and the individual role of these for mBC functionality remain largely unknown. This study characterized the distribution and phenotype of human (Ag-specific) mBCs in peripheral blood (PB), spleen, tonsil, and bone marrow. We found that the spleen harbors most mBCs, followed by tonsils, BM, and PB, and we detected no major differences in expression of markers associated with higher maturity. Testing the distribution of tetanus toxoid-specific (TT(+)) mBCs revealed their presence in PB during steady state, yet absolute numbers suggested their largest reservoir in the spleen, followed by tonsils. To explore the role of both tissues in the maintenance of reactive B cell memory, we revaccinated controls and splenectomized and tonsillectomized individuals with TT. All donor groups exhibited comparable emergence of anti-TT IgG, TT(+) plasma cells, and TT(+) mBCs in the PB, together with similar molecular characteristics of TT(+) plasma cells. In summary, human mBCs recirculate through PB and reside in different lymphoid organs that do not reflect different mBC maturity stages. The spleen and tonsil, although harboring the largest number of overall and TT(+) mBCs, appear to be dispensable to preserve adequate responsiveness to secondary antigenic challenge.


Subject(s)
B-Lymphocytes/immunology , Bone Marrow/immunology , Immunologic Memory/immunology , Palatine Tonsil/immunology , Spleen/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Antigens/immunology , Antigens, CD/immunology , Antigens, CD/metabolism , B-Lymphocytes/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Lymphocyte Count , Male , Middle Aged , Plasma Cells/immunology , Receptors, Antigen, B-Cell/immunology , Receptors, Antigen, B-Cell/metabolism , Tetanus Toxoid/immunology , Young Adult
5.
Immunity ; 38(6): 1223-35, 2013 Jun 27.
Article in English | MEDLINE | ID: mdl-23791642

ABSTRACT

RORγt⁺ innate lymphoid cells (ILCs) are crucial players of innate immune responses and represent a major source of interleukin-22 (IL-22), which has an important role in mucosal homeostasis. The signals required by RORγt⁺ ILCs to express IL-22 and other cytokines have been elucidated only partially. Here we showed that RORγt⁺ ILCs can directly sense the environment by the engagement of the activating receptor NKp44. NKp44 triggering in RORγt⁺ ILCs selectively activated a coordinated proinflammatory program, including tumor necrosis factor (TNF), whereas cytokine stimulation preferentially induced IL-22 expression. However, combined engagement of NKp44 and cytokine receptors resulted in a strong synergistic effect. These data support the concept that NKp44⁺ RORγt⁺ ILCs can be activated without cytokines and are able to switch between IL-22 or TNF production, depending on the triggering stimulus.


Subject(s)
Interleukins/metabolism , Lymphocytes/immunology , Natural Cytotoxicity Triggering Receptor 2/metabolism , Cells, Cultured , Cellular Microenvironment , Homeostasis , Humans , Immunity, Innate , Inflammation Mediators/metabolism , Mucous Membrane/immunology , Natural Cytotoxicity Triggering Receptor 2/immunology , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , Palatine Tonsil/cytology , Palatine Tonsil/immunology , Receptor Cross-Talk , Signal Transduction , Tumor Necrosis Factor-alpha/metabolism , Interleukin-22
6.
Front Immunol ; 4: 499, 2013 Dec 30.
Article in English | MEDLINE | ID: mdl-24416035

ABSTRACT

Natural killer (NK) cells are part of the innate lymphoid cell (ILC) family and represent the main cytotoxic population. NK cells develop from bone marrow common lymphoid progenitors and undergo terminal differentiation in the periphery, where they finally gain their cytotoxic competence as well as the ability to produce IFN-γ in response to engagement of activating receptors. This process has been at least partially elucidated and several markers have been identified to discriminate different NK cell stages and other ILC populations. NK cell terminal differentiation is not only associated with progressive phenotypic changes but also with defined effector signatures. In this essay, we will describe the phenotypic and functional characteristics of the main stages of NK cell development and terminal differentiation and discuss them in light of recent discoveries of novel ILC populations.

7.
Blood ; 116(8): 1299-307, 2010 Aug 26.
Article in English | MEDLINE | ID: mdl-20505160

ABSTRACT

Human natural killer (NK) cells comprise 2 main subsets, CD56(bright) and CD56(dim) cells, that differ in function, phenotype, and tissue localization. To further dissect the heterogeneity of CD56(dim) cells, we have performed transcriptome analysis and functional ex vivo characterization of human NK-cell subsets according to the expression of markers related to differentiation, migration or competence. Here, we show for the first time that the ability to respond to cytokines or to activating receptors is mutually exclusive in almost all NK cells with the exception of CD56(dim) CD62L(+) cells. Indeed, only these cells combine the ability to produce interferon-gamma after cytokines and proliferate in vivo during viral infection with the capacity to kill and produce cytokines upon engagement of activating receptors. Therefore, CD56(dim) CD62L(+) cells represent a unique subset of polyfunctional NK cells. Ex vivo analysis of their function, phenotype, telomere length, frequencies during ageing as well as transfer experiments of NK-cell subsets into immunodeficient mice suggest that CD56(dim) CD62L(+) cells represent an intermediate stage of NK-cell maturation, which after restimulation can accomplish multiple tasks and further develop into terminally differentiated effectors.


Subject(s)
CD56 Antigen/metabolism , Killer Cells, Natural/metabolism , L-Selectin/metabolism , Leukocytes, Mononuclear/metabolism , Lymphocyte Subsets/immunology , Animals , Biomarkers/metabolism , Blotting, Western , Cell Proliferation , Cells, Cultured , Cytokines/metabolism , Cytotoxicity, Immunologic/immunology , Flow Cytometry , Gene Expression Profiling , Humans , Interferon-gamma/metabolism , Killer Cells, Natural/immunology , Killer Cells, Natural/transplantation , Lymphocyte Activation , Lymphocyte Subsets/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred NOD , Mice, SCID , Oligonucleotide Array Sequence Analysis , Receptors, Chemokine/metabolism , Telomere/physiology , Whole-Body Irradiation
8.
Eur J Immunol ; 39(9): 2548-55, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19701893

ABSTRACT

NK-cell tolerance to self is mediated via engagement of inhibitory receptors by cognate MHC molecules. This event is critical for NK-cell education to achieve functional competence. Thus, NK cells expressing self-MHC-specific inhibitory receptors are responsive to activating stimuli while those lacking such receptors are hyporesponsive. Nevertheless, the mechanisms underlying NK-cell education are still poorly understood. Here, we show that after stimulation with cytokines, hyporesponsive NK cells acquire stable expression of killer Ig-like receptors (KIR) as reflected by DNA hypomethylation of their KIR locus. Remarkably, only hyporesponsive NK cells that acquire KIR in the presence of their cognate MHC molecule gain functional competence and this process can occur in the absence of any accessory cells. Acquisition of competence does not result in autoreactivity, since acquired KIR are functional and therefore able to inhibit NK-cell cytotoxicity. Our data demonstrate that competent NK cells can be generated by cytokine stimulation, suggesting that NK-cell education might not only be an early event which takes place during NK-cell development but might also occur in the periphery during an immune response.


Subject(s)
Cytokines/immunology , Cytotoxicity, Immunologic/genetics , Killer Cells, Natural/immunology , CpG Islands , Cytokines/pharmacology , DNA Methylation , Epigenesis, Genetic , Humans , Immunity, Innate/genetics , Killer Cells, Natural/drug effects , Lysosomal-Associated Membrane Protein 1/immunology , NK Cell Lectin-Like Receptor Subfamily C/biosynthesis , NK Cell Lectin-Like Receptor Subfamily C/genetics , Promoter Regions, Genetic , Receptors, KIR/biosynthesis , Receptors, KIR/genetics , Receptors, KIR3DL1/biosynthesis , Receptors, KIR3DL1/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...